A trial of ClearFlow’s PleuraFlow Active Clearance Technology (ACT) has demonstrated the value in adding the system into Enhanced Recovery After Cardiac Surgery (ERAS) cardiac programme protocols.

OMAHA, Neb., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Centese, Inc. announces the results of a newly published peer-reviewed clinical study on its Thoraguard Intelligent Chest Tube Management System for use ...

OMAHA, Neb., July 26, 2022 (GLOBE NEWSWIRE) -- Centese, Inc. announces the first peer-reviewed clinical study on its Thoraguard® digital drainage system for cardiac surgery at Stanford University ...

IRVINE, Calif.--(BUSINESS WIRE)--ClearFlow, Inc., a medical device company based in Irvine, California, has announced positive clinical trial results published in the peer-reviewed Journal of ...

A pre-clinical evaluation of a self-clearing chest tube developed by Clear Catheter Systems Inc. has demonstrated the tube that clears itself works better to drain the chest after surgery than a ...

A new Omaha-based medtech company has developed a self-cleaning chest tube system that provides more precise measurements for monitoring patients recovering from surgery on their heart or lungs.

Placement of a chest tube may be necessary for management of pleural space disease in mammals. This column describes two accepted techniques for thoracostomy tube placement in the dog. A thoracostomy ...